Profile data is unavailable for this security.
About the company
Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria, the Company generates customized phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a phage-display methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is poultry health products offered by the Company.
- Revenue in CAD (TTM)0.00
- Net income in CAD-7.80m
- Incorporated2019
- Employees--
- LocationCytophage Technologies Ltd26 Henlow BayWINNIPEG R3Y 1G4CanadaCAN
- Phone+1 (416) 214-4810
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voyageur Pharmaceuticals Ltd | 0.00 | -1.53m | 9.07m | -- | -- | 9.60 | -- | -- | -0.0112 | -0.0112 | 0.00 | 0.0068 | 0.00 | -- | -- | -- | -67.92 | -74.47 | -111.56 | -120.92 | -- | -- | -- | -- | 0.0896 | -329.90 | 0.0406 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
Khiron Life Sciences Corp | 16.14m | -30.66m | 9.56m | 310.00 | -- | -- | -- | 0.5924 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
Willow Biosciences Inc | 2.87m | -7.72m | 11.54m | 19.00 | -- | 59.16 | -- | 4.02 | -0.0604 | -0.0604 | 0.0222 | 0.0014 | 0.4901 | -- | 6.33 | 151,000.00 | -131.79 | -- | -193.14 | -- | -- | -- | -268.91 | -- | 0.756 | -- | 0.9002 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
Crescita Therapeutics Inc | 17.40m | -2.74m | 11.89m | 80.00 | -- | 0.7406 | -- | 0.6833 | -0.1409 | -0.1409 | 0.8891 | 0.8371 | 0.7243 | 1.29 | 9.27 | 217,537.50 | -11.40 | -0.2457 | -14.88 | -0.3059 | 55.58 | 63.41 | -15.73 | -0.3518 | 1.68 | -- | 0.0545 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
Kane Biotech Inc | 757.12k | -5.48m | 14.50m | -- | -- | -- | -- | 19.16 | -0.042 | 0.0374 | 0.0059 | -0.0055 | 0.1568 | 0.3751 | 3.23 | -- | -113.43 | -77.89 | -- | -- | 60.54 | 43.27 | -723.31 | -241.85 | 0.5679 | -4.73 | 1.43 | -- | -94.42 | -20.26 | -17.29 | -- | -19.41 | -- |
Pharmacielo Ltd | 1.62m | -14.15m | 15.82m | 268.00 | -- | -- | -- | 9.76 | -0.0849 | -0.0849 | 0.0097 | -0.032 | 0.0699 | 1.38 | 24.15 | -- | -61.03 | -- | -165.82 | -- | -86.39 | -- | -873.57 | -- | 0.039 | -2.48 | 1.37 | -- | -70.96 | -- | -12.27 | -- | -- | -- |
Cytophage Technologies Ltd | 0.00 | -7.80m | 17.53m | -- | -- | 3.32 | -- | -- | -0.3779 | -0.3779 | 0.00 | 0.0978 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2374 | -- | -- | -- | -25.88 | -- | -- | -- |
Devonian Health Group Inc | 9.75m | -3.17m | 18.53m | 6.00 | -- | 1.39 | -- | 1.90 | -0.0216 | -0.0216 | 0.0665 | 0.09 | 0.4423 | 33.07 | 2.32 | 1,625,238.00 | -14.37 | -21.02 | -23.15 | -23.96 | 30.95 | 29.96 | -32.50 | -131.97 | 1.06 | -9.41 | 0.1406 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |